The award was presented to Dr. Renata de Freitas Saito and her team for the development of ThromboFlow, a health technology startup focused on onco-hematology.
Experts presented data on the prevalence, transmission, and progression of anal and oropharyngeal cancers associated with HPV, reinforcing vaccination as the primary prevention strategy.
The event will bring together specialists to discuss advances in infectious diseases and hospital infection control in oncology patients.
Event welcomes international guests to discuss cancers caused by HPV.
The course, taught by Prof. Nancy Lan Guo, trained Brazilian students in multi-omics data integration and medical imaging techniques for applications in biomedical research and precision medicine.
Over two days, 55 students engaged with theoretical classes and practical activities in Medical Physics, exploring the use of radiation in diagnosis and cancer treatment.
Theranostic platform combines cisplatin, nanoparticles, and fluorescence to improve treatment delivery and diagnosis.
CAR-T cell therapy has been transforming the treatment of hematological neoplasms, but its implementation in countries such as Brazil still faces significant barriers.
Agreements with major international publishers eliminate article processing charges and expand open-access publishing for Brazilian institutions.
The course will be offered from January 20 to April 30, 2026. Course registrations will close at noon on January 19, 2026.
With lectures, collaborative activities, and a scientific ideation workshop, the event promoted the integration of competencies across USP, presented ongoing research, established the basis for the strategic planning of the C2PO, and reinforced the center’s role as an articulator of precision oncology initiatives within the university.
Letters of intent must be submitted by January 22, 2026.